June 24, 2025

Cannabis Use Linked to Higher Heart Risks

A new systematic review and meta-analysis found that cannabis use is associated with an increased risk of major adverse cardiovascular events—including acute coronary syndrome, stroke, and cardiovascular death—based on data from more than 432 million individuals in 24 observational studies.

Conexiant

June 20, 2025

AI Screening Finds More Aneurysms In Breast MRI

An artificial intelligence system significantly increased detection of thoracic aortic aneurysms during routine breast MRI scans, identifying more cases than standard clinical readings.

Conexiant

June 19, 2025

Plaque Calcification May Predict Future Hemorrhage Risk

New research tracked subclinical carotid plaque changes over six years and found that plaques with calcification were twice as likely to develop intraplaque hemorrhage, with men showing greater risk for complex plaque progression.

Conexiant

June 13, 2025

Weight Loss Drugs Show Promise for Heart Failure

ACC statement highlights semaglutide and tirzepatide as therapies associated with improved symptoms and functional capacity in patients with heart failure with preserved ejection fraction and obesity.

Conexiant

June 10, 2025

Does Combination Therapy Improve Albuminuria?

Finerenone plus empagliflozin reduced urinary albumin-to-creatinine ratio by 29% to 32% more than either drug alone in patients with chronic kidney disease and type 2 diabetes.

Conexiant

June 06, 2025

Higher Fiber Intake Linked to Lower Stroke

A large population study found that higher dietary fiber intake was associated with reduced risk of stroke and improved survival among stroke survivors, with genetic evidence supporting a causal link for small vessel stroke.

Conexiant

June 04, 2025

Big Tobacco's Medical Research Infiltrates Journals

Investigation reveals tobacco-funded studies appear in top medical journals despite industry bans, as companies invest billions in pharmaceutical subsidiaries.

Conexiant

June 03, 2025

Phytosterols May Shield Against Diabetes, CVD

Large Harvard study shows higher phytosterol intake, particularly beta-sitosterol, reduces type 2 diabetes and cardiovascular disease risk by up to 9%.

Conexiant

May 30, 2025

Major Medical Societies Issue GLP-1 Nutrition Guidelines

New advisory addresses nutritional challenges and side effects for obesity treatment

Conexiant